Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-026290
Filing Date
2021-05-11
Accepted
2021-05-11 07:31:08
Documents
59
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q grtx-10q_20210331.htm   iXBRL 10-Q 1358800
2 EX-31.1 grtx-ex311_8.htm EX-31.1 20314
3 EX-31.2 grtx-ex312_7.htm EX-31.2 21347
4 EX-32.1 grtx-ex321_6.htm EX-32.1 8464
5 EX-32.2 grtx-ex322_9.htm EX-32.2 8254
  Complete submission text file 0001564590-21-026290.txt   5079413

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA grtx-20210331.xsd EX-101.SCH 36402
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE grtx-20210331_cal.xml EX-101.CAL 37271
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE grtx-20210331_def.xml EX-101.DEF 79360
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE grtx-20210331_lab.xml EX-101.LAB 285707
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grtx-20210331_pre.xml EX-101.PRE 202858
11 EXTRACTED XBRL INSTANCE DOCUMENT grtx-10q_20210331_htm.xml XML 911942
Mailing Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355
Business Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Filer) CIK: 0001563577 (see all company filings)

EIN.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39114 | Film No.: 21909627
SIC: 2834 Pharmaceutical Preparations